BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34545326)

  • 1. Whole Exome Sequencing Identifies Two Novel Mutations in a Patient with UC Associated with PSC and SSA.
    Wu D; Chen D; Shi W; Liu W; Zhou W; Qian J
    Can J Gastroenterol Hepatol; 2021; 2021():9936932. PubMed ID: 34545326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of miR-506 in ulcerative colitis associated with primary sclerosing cholangitis.
    Kempinska-Podhorodecka A; Adamowicz M; Ostrycharz E; Chmielarz M; Wójcicki M; Milkiewicz P; Milkiewicz M
    Sci Rep; 2021 May; 11(1):10134. PubMed ID: 33980925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Genetic Risk Variants and Clinical Predictors Associated With Primary Sclerosing Cholangitis in Patients With Ulcerative Colitis.
    Wang MH; Friton JJ; Rebert N; Monroe K; Nix BD; Fiocchi C; Raffals LE; Leighton JA; Pasha SF; Picco MF; Newberry RD; Achkar JP; Faubion WA
    Clin Transl Gastroenterol; 2023 Sep; 14(9):e00615. PubMed ID: 37440754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Signatures Discriminate Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis From Patients With Ulcerative Colitis.
    de Krijger M; Hageman IL; Li Yim AYF; Verhoeff J; Garcia Vallejo JJ; van Hamersveld PHP; Levin E; Hakvoort TBM; Wildenberg ME; Henneman P; Ponsioen CY; de Jonge WJ
    Front Immunol; 2022; 13():840935. PubMed ID: 35371111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial markers of colorectal carcinogenesis in ulcerative colitis and primary sclerosing cholangitis.
    Wohl P; Hucl T; Drastich P; Kamenar D; Spicak J; Honsova E; Sticova E; Lodererova A; Matous J; Hill M; Wohl P; Kucera M
    World J Gastroenterol; 2013; 19(14):2234-41. PubMed ID: 23599650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.
    Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA;
    Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncomir MicroRNA-346 Is Upregulated in Colons of Patients With Primary Sclerosing Cholangitis.
    Kempinska-Podhorodecka A; Blatkiewicz M; Wunsch E; Krupa L; Gutkowski K; Milkiewicz P; Milkiewicz M
    Clin Transl Gastroenterol; 2020 Jan; 11(1):e00112. PubMed ID: 31972611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exome sequencing in patient-parent trios suggests new candidate genes for early-onset primary sclerosing cholangitis.
    Haisma SM; Weersma RK; Joosse ME; de Koning BAE; de Meij T; Koot BGP; Wolters V; Norbruis O; Daly MJ; Stevens C; Xavier RJ; Koskela J; Rivas MA; Visschedijk MC; Verkade HJ; Barbieri R; Jansen DBH; Festen EAM; van Rheenen PF; van Diemen CC
    Liver Int; 2021 May; 41(5):1044-1057. PubMed ID: 33590606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4.
    Ellinghaus D; Folseraas T; Holm K; Ellinghaus E; Melum E; Balschun T; Laerdahl JK; Shiryaev A; Gotthardt DN; Weismüller TJ; Schramm C; Wittig M; Bergquist A; Björnsson E; Marschall HU; Vatn M; Teufel A; Rust C; Gieger C; Wichmann HE; Runz H; Sterneck M; Rupp C; Braun F; Weersma RK; Wijmenga C; Ponsioen CY; Mathew CG; Rutgeerts P; Vermeire S; Schrumpf E; Hov JR; Manns MP; Boberg KM; Schreiber S; Franke A; Karlsen TH
    Hepatology; 2013 Sep; 58(3):1074-83. PubMed ID: 22821403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease.
    Gwela A; Siddhanathi P; Chapman RW; Travis S; Powrie F; Arancibia-Cárcamo CV; Geremia A
    J Crohns Colitis; 2017 Sep; 11(9):1124-1134. PubMed ID: 28383652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis.
    Kevans D; Tyler AD; Holm K; Jørgensen KK; Vatn MH; Karlsen TH; Kaplan GG; Eksteen B; Gevers D; Hov JR; Silverberg MS
    J Crohns Colitis; 2016 Mar; 10(3):330-7. PubMed ID: 26526357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease.
    Boonstra K; van Erpecum KJ; van Nieuwkerk KM; Drenth JP; Poen AC; Witteman BJ; Tuynman HA; Beuers U; Ponsioen CY
    Inflamm Bowel Dis; 2012 Dec; 18(12):2270-6. PubMed ID: 22407885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis.
    Navaneethan U; Kochhar G; Venkatesh PG; Lewis B; Lashner BA; Remzi FH; Shen B; Kiran RP
    Gastrointest Endosc; 2012 May; 75(5):1045-1054.e1. PubMed ID: 22405258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis.
    Hov JR; Keitel V; Laerdahl JK; Spomer L; Ellinghaus E; ElSharawy A; Melum E; Boberg KM; Manke T; Balschun T; Schramm C; Bergquist A; Weismüller T; Gotthardt D; Rust C; Henckaerts L; Onnie CM; Weersma RK; Sterneck M; Teufel A; Runz H; Stiehl A; Ponsioen CY; Wijmenga C; Vatn MH; ; Stokkers PC; Vermeire S; Mathew CG; Lie BA; Beuers U; Manns MP; Schreiber S; Schrumpf E; Häussinger D; Franke A; Karlsen TH
    PLoS One; 2010 Aug; 5(8):e12403. PubMed ID: 20811628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Serum sCD40 and a Distinct Colonic T Cell Profile in Ulcerative Colitis Associated With Primary Sclerosing Cholangitis.
    Lampinen M; Vessby J; Fredricsson A; Wanders A; Rorsman F; Carlson M
    J Crohns Colitis; 2019 Mar; 13(3):341-350. PubMed ID: 30383225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis.
    Culver EL; Bungay HK; Betts M; Forde C; Buchel O; Manganis C; Warren BF; Cummings FR; Keshav S; Travis SPL; Chapman RW
    Liver Int; 2020 Nov; 40(11):2744-2757. PubMed ID: 32841490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of ulcerative colitis on liver-related outcomes of children with primary sclerosing cholangitis.
    Sathiaseelan M; Bolia R; Barallon R; Alex G; Hardikar W; Rajanayagam J
    J Paediatr Child Health; 2022 Jul; 58(7):1221-1227. PubMed ID: 35373867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulated eosinophil activity in ulcerative colitis with concomitant primary sclerosing cholangitis.
    Lampinen M; Fredricsson A; Vessby J; Martinez JF; Wanders A; Rorsman F; Carlson M
    J Leukoc Biol; 2018 Jul; 104(1):173-183. PubMed ID: 29603385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole blood RNA sequencing identifies transcriptional differences between primary sclerosing cholangitis and ulcerative colitis.
    Wacker EM; Uellendahl-Werth F; Bej S; Wolkenhauer O; Vesterhus M; Lieb W; Franke A; Karlsen TH; Folseraas T; Ellinghaus D
    JHEP Rep; 2024 Feb; 6(2):100988. PubMed ID: 38304234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis.
    Vessby J; Lampinen M; Åberg M; Rorsman F; Siegbahn A; Wanders A; Carlson M
    Ups J Med Sci; 2019 Nov; 124(4):238-245. PubMed ID: 31774347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.